Intellectual Property

Dr David Torstensson and U.S. Chamber of Commerce launch new fourth edition of the Global Rule of Law and Business Dashboard

Posted by:

Last week Dr David Torstensson presented the findings of the 2019 Global Rule of Law and Business Dashboard at the U.S. Chamber of Commerce in Washington D.C.

Titled Laying the Foundation for Prosperity the Dashboard offers the business community, governments, policymakers and stakeholders across the world an innovative, empirical tool to measure and understand the particular needs of the business community within a rule of law context. What are the issues that are important to business? What is currently being ...

Continue Reading →
0

Pugatch Consilium is releasing the sixth edition of the Building the Bioeconomy

Posted by:

Pugatch Consilium is today releasing the sixth edition of the Building the Bioeconomy, a series of papers commissioned by the Biotechnology Industry Organization. Since 2013, the series has taken the pulse of biotechnology policies in the main economies worldwide, and has shown that policy choices are key determinants of success in growing biotechnology sectors.
This year’s edition adds to the analysis eleven countries, further increasing the geographic and economic diversity of the countries sampled. Yet, the findings of the report ...

Continue Reading →
0

New Pugatch Consilium Study Shows How Countries Can Develop Biotech Industry

Posted by:

A Pugatch Consilium study released today commissioned by the Biotechnology Innovation Organization (BIO) highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.

The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from public policy inputs to biotechnology outputs, the report provides a full and detailed ...

Continue Reading →
0

Why IP Incentives Matter for Life Sciences Innovation – In Europe and Beyond

Posted by:

Why IP incentives matter for life sciences innovation – In Europe and Beyond

Pugatch Consilium is today releasing a new report – A Critical Incentive – Not a Barrier! How IP incentives spur biopharmaceutical innovation and the creation of new health technologies.

This report examines the importance of IP based incentives to biopharmaceutical innovation and the development of new medicines and medical technologies.

This analysis could not be more timely. In Europe, for example, the EU Commission is seriously considering ways to ...

Continue Reading →
0